SCHEMBL7107785

SCHEMBL7107785

CN(Cc1cncc(CN(C)CC(O)C(O)CO)n1)CC(O)C(O)CO

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MTAP Q13126 2/20 0.32
TYMP P19971 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7108601 0.85 TYMP (0.39) TYMP
SCHEMBL7663640 0.83 GRIN2D (0.36) MTAP
SCHEMBL7110095 0.83 MTAP (0.34) MTAPTYMP
SCHEMBL7106657 0.83 PNP (0.39)
SCHEMBL7661155 0.80 CHRNB2 (0.38) MTAP
SCHEMBL7106669 0.77 PNP (0.41)
SCHEMBL7108544 0.75 PNP (0.36)
SCHEMBL7650963 0.75 KMT2A (0.39)
SCHEMBL7109239 0.73 HSD17B10 (0.41)
SCHEMBL7107159 0.72 LMNA (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001944-B1 PYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM AVENTIS PHARMA SA (FR) 2003-10-01 EP claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed